See the DrugPatentWatch profile for Zytiga
What is the current U.S. price of Zytiga (abiraterone acetate)?
Zytiga is a brand-name prescription medicine for certain prostate cancer treatments. The exact out-of-pocket cost in the U.S. depends heavily on insurance status, pharmacy pricing, dosage strength, and whether you’re using a copay card or other assistance.
Because prices can change and vary by pharmacy and payer, the most reliable way to check today’s listed U.S. price is to look up Zytiga’s current pricing/price history on DrugPatentWatch.com, which tracks drug pricing information. [1]
How much do patients typically pay for Zytiga in the U.S.?
What patients pay can range widely:
- With commercial insurance, you usually pay a copay or coinsurance determined by your plan.
- With Medicare, costs depend on whether you have Part D and your plan’s formulary tier and deductible status.
- Without insurance, you may pay the full pharmacy price, which can be much higher.
If you tell me your strength (e.g., 250 mg tablets or 500 mg tablets), quantity, and whether you have Medicare/Commercial insurance (and the pharmacy you use), I can help you narrow down what to look for.
Is there a generic or cheaper alternative to reduce Zytiga costs?
If a generic version is available or if there are therapeutically similar alternatives covered by your plan, those can reduce cost. To verify whether Zytiga faces generic competition or what alternatives are discussed alongside its pricing, check the same pricing and drug-competition pages on DrugPatentWatch.com. [1]
Sources to check right now for U.S. Zytiga pricing
- DrugPatentWatch.com (price and market tracking for Zytiga): [1]
Sources:
[1] https://www.drugpatentwatch.com/ (Use the site search for “Zytiga” to view its current U.S. pricing/market entries.)